|
|
|
Insider
Information: |
Khattar Jack A. |
Relationship: |
Director |
City: |
Rockville |
State: |
MD |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
4 |
|
Direct
Shares |
1,389,796 |
|
Indirect Shares
|
2,118,700 |
|
|
Direct
Value |
$28,498,312 |
|
|
Indirect Value
|
$31,460,787 |
|
|
Total
Shares |
3,508,496 |
|
|
Total
Value |
$59,959,099 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
1
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
1
|
|
|
|
Gain/Loss Ratio : |
0.0
|
-1.0
|
Percentage
Gain/Loss : |
0.0%
|
-42.9%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Supernus Pharmaceuticals Inc |
SUPN |
President, CEO, Director |
2024-09-03 |
926,172 |
2024-09-03 |
1,022,450 |
Premium* |
|
Tesaro, Inc. |
TSRO |
President, CEO, Director |
2016-03-29 |
444,124 |
2016-03-29 |
1,096,250 |
Premium* |
|
Scpharmaceuticals Inc. |
SCPH |
Director |
2021-12-03 |
5,000 |
2021-12-03 |
0 |
Premium* |
|
Cognition Therapeutics Inc |
CGTX |
Director |
2024-06-07 |
14,500 |
2023-06-09 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
101 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 3 of 5
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
SUPN |
Supernus Pharmaceuticals ... |
President, CEO |
|
2022-08-15 |
4 |
AS |
$34.03 |
$588,752 |
D/D |
(17,302) |
759,901 |
0 |
% |
|
SUPN |
Supernus Pharmaceuticals ... |
President, CEO |
|
2022-08-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
46,575 |
788,016 |
0 |
- |
|
SUPN |
Supernus Pharmaceuticals ... |
President, CEO |
|
2022-08-16 |
4 |
AS |
$34.01 |
$499,651 |
D/D |
(14,690) |
775,559 |
0 |
% |
|
SUPN |
Supernus Pharmaceuticals ... |
President, CEO |
|
2022-08-16 |
4 |
OE |
$34.01 |
$312,307 |
D/D |
9,182 |
790,249 |
0 |
- |
|
SUPN |
Supernus Pharmaceuticals ... |
President, CEO |
|
2022-08-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
39,530 |
799,431 |
0 |
- |
|
SUPN |
Supernus Pharmaceuticals ... |
President, CEO |
|
2022-09-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,895 |
781,454 |
0 |
- |
|
SUPN |
Supernus Pharmaceuticals ... |
President, CEO |
|
2022-09-14 |
4 |
OE |
$33.75 |
$46,575 |
D/D |
1,380 |
780,074 |
0 |
- |
|
SUPN |
Supernus Pharmaceuticals ... |
President, CEO |
|
2022-11-15 |
4 |
AS |
$35.00 |
$39,028 |
D/D |
(1,115) |
780,742 |
0 |
% |
|
SUPN |
Supernus Pharmaceuticals ... |
President, CEO |
|
2022-11-15 |
4 |
OE |
$9.56 |
$17,045 |
D/D |
1,783 |
781,857 |
0 |
- |
|
SUPN |
Supernus Pharmaceuticals ... |
President, CEO |
|
2022-11-21 |
4 |
OE |
$9.56 |
$8,107 |
D/D |
848 |
781,590 |
0 |
- |
|
SUPN |
Supernus Pharmaceuticals ... |
President, CEO |
|
2022-11-21 |
4 |
AS |
$35.01 |
$18,592 |
D/D |
(531) |
781,059 |
0 |
% |
|
SUPN |
Supernus Pharmaceuticals ... |
President, CEO |
|
2022-11-22 |
4 |
AS |
$35.00 |
$21,001 |
D/D |
(600) |
781,418 |
0 |
% |
|
SUPN |
Supernus Pharmaceuticals ... |
President, CEO |
|
2022-11-22 |
4 |
OE |
$9.56 |
$9,168 |
D/D |
959 |
782,018 |
0 |
- |
|
SUPN |
Supernus Pharmaceuticals ... |
President, CEO |
|
2022-11-23 |
4 |
AS |
$35.05 |
$79,189 |
D/D |
(2,259) |
782,775 |
0 |
% |
|
SUPN |
Supernus Pharmaceuticals ... |
President, CEO |
|
2022-11-23 |
4 |
OE |
$9.56 |
$34,569 |
D/D |
3,616 |
785,034 |
0 |
- |
|
SUPN |
Supernus Pharmaceuticals ... |
President, CEO |
|
2022-11-25 |
4 |
OE |
$9.56 |
$170,111 |
D/D |
17,794 |
800,569 |
0 |
- |
|
SUPN |
Supernus Pharmaceuticals ... |
President, CEO |
|
2022-11-25 |
4 |
AS |
$35.18 |
$391,685 |
D/D |
(11,135) |
789,434 |
0 |
% |
|
SUPN |
Supernus Pharmaceuticals ... |
President, CEO |
|
2022-12-20 |
4 |
AS |
$38.02 |
$152,317 |
D/D |
(4,006) |
791,956 |
0 |
% |
|
SUPN |
Supernus Pharmaceuticals ... |
President, CEO |
|
2022-12-20 |
4 |
OE |
$9.56 |
$62,408 |
D/D |
6,528 |
795,962 |
0 |
- |
|
SUPN |
Supernus Pharmaceuticals ... |
President, CEO |
|
2022-12-21 |
4 |
A |
$0.00 |
$0 |
D/D |
15,625 |
807,581 |
0 |
- |
|
SUPN |
Supernus Pharmaceuticals ... |
President, CEO |
|
2022-12-21 |
4 |
OE |
$9.56 |
$176,592 |
D/D |
18,472 |
826,053 |
0 |
- |
|
SUPN |
Supernus Pharmaceuticals ... |
President, CEO |
|
2022-12-21 |
4 |
AS |
$38.14 |
$433,070 |
D/D |
(11,354) |
814,699 |
0 |
% |
|
SUPN |
Supernus Pharmaceuticals ... |
President, CEO |
|
2023-01-17 |
4 |
AS |
$40.03 |
$1,018,728 |
D/D |
(25,446) |
791,173 |
0 |
% |
|
SUPN |
Supernus Pharmaceuticals ... |
President, CEO |
|
2023-01-17 |
4 |
OE |
$9.56 |
$400,755 |
D/D |
41,920 |
816,619 |
0 |
- |
|
SUPN |
Supernus Pharmaceuticals ... |
President, CEO |
|
2023-01-18 |
4 |
OE |
$9.56 |
$77,245 |
D/D |
8,080 |
799,253 |
0 |
- |
|
101 Records found
|
|
Page 3 of 5 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|